Marksans Pharma share price target: 2024, 2025, 2026, 2027, 2028, 2029, and 2030

In this article, we will try to analyze the share price target of Marksans Pharma for 2024, 2025, 2026, 2027, 2028, 2029, and 2030 based on the company’s financials and various reports from research and brokerage firms.

Introduction–

Marksans Pharma Ltd. is an Indian pharmaceutical company that engages in the research, manufacturing, and marketing of pharmaceutical formulations. The company manufactures a wide range of solid oral dosages in the form of tablets, hard gelatin capsules, and soft gelatin capsules.

The company has targeted the US pharmaceutical market as its primary market. Marksans Pharma’s Goa manufacturing plant is one of the biggest manufacturing units for soft gelatin capsules and tablets in Asia.

Recent News-

The company reported its highest revenue of Rs 550 crore in Quarter 3.

The company reported its highest ever Rs 84 crore profit in Quarter 3.

The net worth of Marksans Pharma has significantly increased to 1,765 crore.

Promoters shareholding has decreased 4.75% in the last year.

Foreign institutional investors have significantly increased their positions in holding stakes.

Company Overview-

Marksans Pharma Limited is engaged in the business of formulating pharmaceutical products. The company’s focus areas lie in OTC and prescription drugs that have wide-ranging applications across fields like oncology, gastroenterology, anti-diabetics, antibiotics, cardiovascular, pain management, and gynecology, among others.

Join our whatsApp channel for latest updates

Stockmoodys

Marksans Pharma Ltd. has the latest technology and automated manufacturing and packing units, ensuring the highest quality of healthcare.

Financials–

Market Cap	7,294
P/E Ratio	22.99
Industry P/E	36.96
Debt to Equity	0.06
Return on Equity	15.86%
Dividend Yield	0.32%

Net-profit margin-

Year	Revenue	Profit
2023	1,911	265
2022	1,533	187
2021	1,383	239
2020	1,135	121
2019	1,005	80

	Dec’23	Sep’23	Jun’23	Mar’23	Dec’22	Sep’22
Promoters	43.85%	43.85%	43.85%	43.85%	49.00%	48.60%
Retail	36.78%	37.93%	38.46%	40.18%	45.81%	46.39%
Foreign Instutution	15.55%	15.07%	14.90%	15.11%	4.23%	4.06%
Mutual Funds	3.82%	3.15%	2.79%	0.86%	0.96%	0.95%

Share price targets for Marksans Pharma are highly speculative and influenced by numerous factors, such as market conditions, economic indicators, company performance, industry trends, and many more.

We will predict the Marksans Pharma share price target in 2024, 2025, 2026, 2027, 2028, 2029, and 2030 by analyzing the previous performance and after studying various brokerage and research firm forecasts.

Marksans Pharma has delivered compound sales growth of 16% over the last 10 years.

2024	Minimum Share Price	Maximum Share Price
January 2024	148	172
February 2024	145	183
March 2024	133	188
April 2024	147	194
May 2024	155	205
June 2024	172	215
July 2024	181	230
August 2024	194	238
September 2024	205	244
October 2024	211	256
November 2024	218	261
December 2024	227	280

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 280 in December 2024 and a minimum price target of Rs 133 in March 2024. The average price target for Marksans Pharma in 2024 is expected to be around Rs 190.

Marksans Pharma Share price target prediction for 2024 is based on the company’s financials, previous trends, and various brokerage firm reports.

Marksans Pharma has delivered compound profit growth of 52% over the last 5 years.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 410 in October 2025 and a minimum price target of Rs 290 in May 2025. The average price target for Marksans Pharma in 2025 is expected to be around Rs 355.

Marksans Pharma Share price target prediction for 2025 is based on the company’s financials, previous trends, and various brokerage firm reports.

Marksans Pharma has delivered stock price growth of 41% CAGR over the last 5 years.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 584 in December 2026 and a minimum price target of Rs 388 in feb 2026. The average price target for Marksans Pharma in 2026 is expected to be around Rs 450.

Marksans Pharma Share price target prediction for 2026 is based on the company’s financials, previous trends, and various brokerage firm reports.

Marksans Pharma has delivered a 21% return on equity in the last 5 years.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 720 in December 2027 and a minimum price target of Rs 555 in March 2027. The average price target for Marksans Pharma in 2027 is expected to be around Rs 635.

Marksans Pharma Share price target prediction for 2027 is based on the company’s financials, previous trends, and various brokerage firm reports.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 1045 in December 2028 and a minimum price target of Rs 755 in March 2028. The average price target for Marksans Pharma in 2028 is expected to be around Rs 918.

Marksans Pharma Share price target prediction for 2028 is based on the company’s financials, previous trends, and various brokerage firm reports.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 1345 in December 2025 and a minimum price target of Rs 955 in March 2029. The average price target for Marksans Pharma in 2029 is expected to be around Rs 1166.

Marksans Pharma Share price target prediction for 2029 is based on the company’s financials, previous trends, and various brokerage firm reports.

The share price of Marksans Pharma is expected to continue experiencing volatility throughout the year, with a maximum price target of Rs 1548 in December 2030 and a minimum price target of Rs 1240 in March 2030. The average price target for Marksans Pharma in 2030 is expected to be around Rs 1392.

Marksans Pharma Share’s price target prediction for 2030 is based on the company’s financials, previous trends, and various brokerage firm reports.

Strengths of Marksans Pharma

Marksans Pharma is almost debt-free.

The company has delivered good profit growth of 51.8% CAGR over the last 5 years.

The company has been paying dividends to its investors consistently for the last 10 years.

Weaknesses of Marksans Pharma

Promoter Holding has decreased 4.70% over the past year.

Competitor

Company	Market cap	P/E Ratio
Torrent Pharma	72559	53.99
Gland Pharma	30304	38.46
Ajanta Pharma	23801	36.07
Lauras Labs	21511	59.63
ERIS Lifesciences	11963	31.67

Conclusion

Marksans Pharma Limited has good financials and is consistently performing well. The company is the 6^th largest company in the pharmaceutical industry, with a strong presence in the domestic and international markets. The company reported its highest sales in the financial year 2023.

Overall, Marks Pharma’s performance is characterized by its resilience, growth potential, and commitment to delivering value to its stakeholders.

All market experts are positive about the stock predictions and their targets.